Alliances
The new deal builds on a discovery agreement signed in October 2017.
Heidelberg Pharma contributing Antibody Targeted Amanitin Conjugate technology for Emergence Therapeutics antibody target
Regenstrief Institute is investing and partnering with Care Revolution, a medical startup focused on improving care at nursing facilities, controlling costs and reducing trips to the hospital.
At the center of the agreement are Dragonfly’s novel NK cell engager-based immunotherapies.
New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop
The research will focus on nanotechnology based CBD- products for the treatment of psoriasis and other diseases
They will leverage Dicerna’s GalXC RNAi technology platform to explore more than 30 liver cell targets.
ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement.
OKRA Technologies, a leading provider of Artificial Intelligence driven analytics for global life sciences, announced they are joining the Veeva Technology Partnership Program and will be making their proprietary AI outputs available to Veeva CRM customers.
The research pact will leverage Dewpoint’s biomolecular condensates technology platform and Bayer’s small molecule compound library to identify and develop new therapies for cardiovascular and gynecological diseases.
PRESS RELEASES